Analysis of MRSA-attributed costs of hospitalized patients in Germany

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 10, 2014, Pages 1817-1822

  Hubner C ^a   Hubner N O ^b   Hopert, K ^a   Maletzki, S ^b   Flessa, S ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COST BENEFIT ANALYSIS; GERMANY; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; CASE MANAGEMENT; ECONOMICS; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATIENT CARE; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE MANAGEMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INFANT; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PATIENT ISOLATION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84911003573     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2131-x     Document Type: Article

References (22)

1. Gould IM (2005) The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 61(4):277–282
2. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG Jr (2005) Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26(2):175–183
3. de Kraker ME, Davey PG, Grundmann H; BURDEN study group (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8(10):e1001104
4. Köck R, Becker K, Cookson B, van Gemert-Pijnen JE, Harbarth S, Kluytmans J, Mielke M, Peters G, Skov RL, Struelens MJ, Tacconelli E, Navarro Torné A, Witte W, Friedrich AW (2010) Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill 15(41):19688
5. Hubben G, Bootsma M, Luteijn M, Glynn D, Bishai D, Bonten M, Postma M (2011) Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus. PLoS One 6(3):e14783
6. Murthy A, De Angelis G, Pittet D, Schrenzel J, Uckay I, Harbarth S (2010) Cost-effectiveness of universal MRSA screening on admission to surgery. Clin Microbiol Infect 16(12):1747–1753
7. Uçkay I, Sax H, Iten A, Camus V, Renzi G, Schrenzel J, Perrier A, Pittet D (2008) Effect of screening for methicillin-resistant Staphylococcus aureus carriage by polymerase chain reaction on the duration of unnecessary preemptive contact isolation. Infect Control Hosp Epidemiol 29(11):1077–1079
8. van Rijen MM, Kluytmans JA (2009) Costs and benefits of the MRSA search and destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis 28(10):1245–1252
9. Wassenberg MWM, Kluytmans JAJW, Box ATA, Bosboom RW, Buiting AGM, van Elzakker EPM, Melchers WJG, van Rijen MML, Thijsen SFT, Troelstra A, Vandenbroucke-Grauls CMJE, Visser CE, Voss A, Wolffs PFG, Wulf MWH, van Zwet AA, de Wit GA, Bonten MJM (2010) Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects. Clin Microbiol Infect 16(12):1754–1761
10. Geldner G, Ruoff M, Hoffmann HJ, Kiefer P, Georgieff M, Wiedeck H (1999) Cost analysis concerning MRSA-infection in ICU. Anasthesiol Intensivmed Notfallmed Schmerzther 34(7):409–413
11. Ott E, Bange FC, Reichardt C, Graf K, Eckstein M, Schwab F, Chaberny IF (2010) Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. J Hosp Infect 76(4):300–303
12. Herr CEW, Heckrodt TH, Hofmann FA, Schnettler R, Eikmann TF (2003) Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect Control Hosp Epidemiol 24(9):673–678
13. Wernitz MH, Keck S, Swidsinski S, Schulz S, Veit SK (2005) Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect 11(6):466–471
14. Resch A, Wilke M, Fink C (2009) The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals. Eur J Health Econ 10(3):287–297
15. Gastmeier P (2014) Krankenhaushygiene und Infektionsvermeidung. In: Klauber J, Geraedts M, Friedrich J, Wasem J (eds) Krankenhaus-report 2014. Schattauer-Verlag, Stuttgart, pp 113–123
16. Loveday HP, Pellowe CM, Jones SR, Pratt RJ (2006) A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996–2004): report to the Joint MRSA Working Party (Subgroup A). J Hosp Infect 63(Suppl 1):S45–S70
17. DeWitt TG (1987) How problematic are nosocomial infections in the DRG reimbursement system? Am J Public Health 77(5):542–543
18. Strübing V, Dittberner T, Metelmann C, Hübner NO (2011) Uniform documentation of measures in cases of MRSA—an important step towards improving the quality of treatment. GMS Krankenhhyg Interdiszip 6(1):Doc21
19. Haubrock M (2007) Krankenhausfinanzwirtschaft. In: Haubrock M, Schär W (eds) Betriebswirtschaft und Management im Krankenhaus. Huber, Bern, pp 394–453
20. Kalenic S, Cookson B, Gallagher R, Popp W, Asensio-Vegas A, Assadian O, Blok A, Brussafero S, Eastaway A, Elstrom P, Girod Schreinerova M, Hartemann P, Iversen RBG, Jans B, Jul-Jorgensen A, Koller W, Kramer A, Laugesen D, Licker M, Mannerquist K, Nussbaum B, Parneix P, de Ruiter T, Tvenstrup Jensen E, Ummels L, Zastrow K-D (2010) Comparison of recommendations in national/regional Guidelines for prevention and control of MRSA in thirteen European countries. Int J Infect Control 6(2)
21. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM; SHEA (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24(5):362–386
22. Hübner C, Hübner N-O, Muhr M, Claus F, Leesch H, Kramer A, Fleßa S (2013) Kostenanalyse der stationär behandelten Clostridium-difficile-assoziierten Diarrhö (CDAD). Gesundh ökon Qual manag 18(2):80–85